| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/21/2026 | ±2.1% | +0.2% | over-priced |
| 05/01/2026 | ±3.3% | -3.0% | over-priced |
| 01/30/2026 | ±2.3% | -1.3% | over-priced |
| 11/07/2025 | ±3.3% | +1.2% | over-priced |
| 08/22/2025 | ±1.7% | +2.6% | under-priced |
| 05/06/2025 | ±2.9% | -0.4% | over-priced |
| 01/31/2025 | ±2.6% | +0.5% | over-priced |
| 11/05/2024 | ±2.1% | +2.4% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2026 | — | $5.8B | $1.1B |
| Q3 FY2026 | $7.06 | $5.5B | $904M |
| Q2 FY2026 | $6.60 | $5.2B | $845M |
| Q1 FY2026 | $6.29 | $5.1B | $808M |
Parker-Hannifin Corporation (PH) reports in 23 days, with the next report estimated for 11/20/2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced PH's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 9.8%. QuantLogix's live 5-factor engine currently reads PH as a underweight at 41/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →